You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 5, February 1, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •World Health
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa

Anthon du P. Heyns, DSc, MD; Richard J. Benjamin, MBChB, PhD; J. P. Ronel Swanevelder, MSc; Megan E. Laycock, BS; Brandee L. Pappalardo, PhD; Robert L. Crookes, MBChB; David J. Wright, PhD; Michael P. Busch, MD, PhD

JAMA. 2006;295:519-526.

Context  The South African National Blood Service collects more than 700 000 units of blood annually from a population in which 11.4% is infected with human immunodeficiency virus 1 (HIV-1). The prevalence of HIV-1 in blood donations increased to 0.26% (1:385) in 1998, indicating that a significant number of window-period infective units were entering the blood supply (risk 3.4/100 000).

Objectives  To determine whether the implementation of a new donor selection policy and educational program introduced in 1999 was associated with reductions in the incidence and prevalence of HIV-1 in blood donations and the reduced transmission risk.

Design  We compared the prevalence of HIV-1 in 880 534 blood donations collected from 1999 through 2000 with the 791 639 blood donations collected from 2001 through 2002. We estimated the incidence of HIV-1 in 93 378 (1999-2000) and 67 231 (2001-2002) first-time donations and the residual risk for all donations in 2001-2002 using the less-sensitive enzyme-linked immunoassay and incidence-window period model.

Setting  All blood donors in the Inland region of the South African National Blood Service were analyzed.

Intervention  Donor clinics in high HIV prevalence areas were closed. Programs targeting repeat donors and youth were initiated and HIV risk behavior education programs were developed. Structured donor interviews and an enhanced donor self-exclusion questionnaire were institutionalized.

Results  The prevalence of HIV-1 in blood donations declined from 0.17% in 1999-2000 to 0.08% in 2001-2002 after the implementation of the new donor selection and education policy. The number of high-risk donations collected decreased from 2.6% to 1.7% (P<.001), and the likelihood of these donations being infected decreased from 4.8% to 3.25%. The likelihood of first-time donors being recently infected with HIV-1 decreased from 18% to 14% (P = .07) and respective incidence of high-risk donations collected decreased from 2.6% to 1.7%. Donations from the majority black population declined from 6.6% to 4.2% (P<.001). Analysis of HIV-1 incidence in 2001-2002 suggests a residual risk of collecting a window period infectious unit of 2.6/100 000.

Conclusion  The implementation of enhanced education and selection policies in South Africa was associated with decreased prevalence of HIV-1 in blood donations.


Author Affiliations: South African National Blood Service, Weltevreden Park, South Africa (Drs Heyns and Crookes and Ms Swanevelder); Joint Program in Transfusion Medicine, Harvard University, Boston, and American Red Cross Blood Services, New England Region, Dedham, Mass (Dr Benjamin); Blood Systems Research Institute, San Francisco, Calif (Ms Laycock and Drs Pappalardo and Busch); Westat Inc, Rockville, Md (Dr Wright); and University of California, San Francisco (Dr Busch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Blood Safety—At What Cost?
Linda-Gail Bekker and Robin Wood
JAMA. 2006;295(5):557-558.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors
Gray et al.
J. Virol. 2009;83:8925-8937.
ABSTRACT | FULL TEXT  

High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection
Ma et al.
J. Virol. 2009;83:3288-3297.
ABSTRACT | FULL TEXT  

HIV prevention for a threatened continent: implementing positive prevention in Africa.
Bunnell et al.
JAMA 2006;296:855-858.
FULL TEXT  

Blood Safety--At What Cost?
Bekker and Wood
JAMA 2006;295:557-558.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.